Clinical and Microbiological Aspects of Probiotics in Non-surgical Periodontal Therapy.
Launched by G. D'ANNUNZIO UNIVERSITY · Sep 26, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether taking specific probiotics—Lactobacillus rhamnosus LR04 and Lactobacillus plantarum LP14—can help people with moderate to severe gum disease, known as periodontitis. The researchers want to find out if these probiotics can improve gum health when taken alongside regular oral hygiene practices, like brushing and flossing. Participants will be divided into three groups: one group will take the probiotics for 90 days, another will receive a placebo (which looks like the probiotics but has no active ingredients), and the last group will only follow their usual oral care routine without any additional treatment.
To participate in this study, individuals should be between 65 and 74 years old, and they must not have any serious health conditions like diabetes or autoimmune diseases. They should also not be current drinkers or have taken probiotics in the last three months. If eligible, participants can expect to take the assigned treatment for 90 days and regularly check in with the researchers about their gum health. This trial is not yet recruiting, so it’s a good time to learn more about it if you or someone you know is dealing with gum issues.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients in the absence of other systemic pathologies reported in the medical history
- • smokers and non-smokers, non-drinkers,
- • subjects in the absence of previous or current administration of other sources of probiotics,
- • subjects capable of providing informed consent.
- Exclusion Criteria:
- • Subjects with a history of systemic diseases (diabetes, autoimmune diseases, inflammatory bowel diseases, neurodegenerative diseases),
- • drinkers,
- • subjects who take or have taken probiotics in the last 3 months,
- • subjects unable to provide informed consent.
About G. D'annunzio University
G. D'Annunzio University, located in Chieti-Pescara, Italy, is a prominent academic institution committed to advancing scientific research and innovation in the health sciences. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages the development of novel therapeutic strategies and clinical applications. As a clinical trial sponsor, G. D'Annunzio University seeks to contribute to the improvement of patient outcomes through rigorous research methodologies, ethical standards, and a focus on translational medicine. Their dedication to education and research excellence positions them as a key player in the advancement of healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chieti, , Italy
Patients applied
Trial Officials
Marco Dolci, MD DDS PHD
Principal Investigator
University G. d'Annunzio of Chieti
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported